ハッショウマメ（<i>Mucuna pruriens</i>）の個人間インターネット取引での広告・販売の実態に関する調査

DOI Web Site Web Site PubMed 参考文献9件
  • 佐藤 謙一郎
    東京大学医学部附属病院早期探索開発推進室 東京大学大学院医学系研究科神経病理学
  • 肥田 あゆみ
    明理会東京大和病院脳神経内科 第一東京弁護士会
  • 新美 芳樹
    東京大学医学部附属病院早期探索開発推進室
  • 岩田 淳
    東京都健康長寿医療センター脳神経内科
  • 岩坪 威
    東京大学医学部附属病院早期探索開発推進室 東京大学大学院医学系研究科神経病理学

書誌事項

タイトル別名
  • Survey on the Current Advertising and Sales of <i>Mucuna pruriens</i> in Consumer-to-consumer Internet Trading in Japan
  • ハッショウマメ(Mucuna pruriens)の個人間インターネット取引での広告・販売の実態に関する調査
  • ハッショウマメ(Mucuna pruriens)ノ コジン カン インターネット トリヒキ デ ノ コウコク ・ ハンバイ ノ ジッタイ ニ カンスル チョウサ

この論文をさがす

抄録

<p>Mucuna pruriens (MP) is leguminous plant which contains 5% of L-3,4-dihydroxyphenylalanine (levodopa) in its seeds. It may have a potential to be used as an alternative therapy for Parkinson’s disease (PD). Meanwhile, there is a concern in terms of public health that MP products can be overused by patients with PD. As an entry for patients with PD to acquire MP products in Japan, they are often purchased via internet auctions or free markets. MP products are not reagrded as ‘pharmatheutical’ by Japanese law as long as the specific legal requirements on advertisements are met, so that the MP products can be advertised or sold without any permission from the authorities. In this study, we aimed to conduct internet survey as to the complianse status of these legal requirements. Several major internet auction or free market websites in Japan were surveyed in May–June 2023 by the authors, and 1157 MP product pages were examined. We found approximately 30–40% of the MP products were suspected to have potential legal risks in terms of their advertisements in their website descriptions, such as claiming pharmatheutical efficacy or describing pharmatheutical-like dosages. In addition, approximately 30–40% of the MP products also did not refer to cautions not to take MP products excessively because of the levodopa ingredients. Current study suggested the need of careful description of the MP products in the auction or free market websites for the MP products exhibitors or sellers, in order to fullfill legal requirements as well as to prevent MP abuse.</p>

収録刊行物

  • 薬学雑誌

    薬学雑誌 143 (12), 1057-1067, 2023-12-01

    公益社団法人 日本薬学会

参考文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ